Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1976 Jan;73(1):228-32.
doi: 10.1073/pnas.73.1.228.

Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines

Case Reports

Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines

A L Epstein et al. Proc Natl Acad Sci U S A. 1976 Jan.

Abstract

Tumor cell lines have been established in continuous culture from two North American Burkitt's lymphomas. The SU-AmB-1 line, derived from a patient with low serum antibody titers to Epstein-Barr virus (EBV), was devoid of EBV genomes by the reaction for EBV-associated nuclear antigen (EBNA), could not be induced to express EBV antigens, and was highly refractory to EBV superinfection. Conversely, the SU-AmB-2 cell line, derived from a patient with "African type" serology, yielded a positive EBNA reaction and was readily inducible and superinfectable. Although both cell lines possessed B (bone-marrow-derived) cell characteristics, they had different surface marker patterns. It is postulated that two different classes of undifferentiated B cell lymphomas exist, one of which is positive for the presence of EBV genomes and occurs endemically in Africa and New Guinea and sporadically in other parts of the world, the other of which is EBV-negative and occurs sporadically throughout the world, including the endemic areas.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer. 1965 Apr;18:418-30 - PubMed
    1. J Immunol. 1975 Apr;114(4):1210-2 - PubMed
    1. Int J Cancer. 1975 Jul 15;16(1):125-33 - PubMed
    1. J Exp Med. 1971 Jan 1;133(1):156-67 - PubMed
    1. Nature. 1972 May 5;237(5349):33-4 - PubMed

Publication types